Jennifer Anolik
| Title | Associate Professor |
|---|
| Institution | School of Medicine and Dentistry |
|---|
| Department | Medicine |
|---|
| Address | University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 695
Rochester NY 14642
|
|---|
|
|
|
| Title | Associate Professor |
|---|
| Institution | School of Medicine and Dentistry |
|---|
| Department | Pathology and Laboratory Medicine |
|---|
|
|
|---|
|
| 1987 |
|
| Summer Research Fellowship | Dana Foundation | | 1988 |
-
| 1990 | Medical Scientist Training Program Scholarship | NIH | | 1988 |
|
| Phi Beta Kappa | | 1988 |
|
| Sigma Xi Scientific Research Society | | 1988 |
|
| Outstanding Senior Chemistry Student Award | American Institutue ofChemists | | 1988 |
-
| 1989 | Dean's Letter of Recognition | University of Rochester | | 1991 |
-
| 1992 | Stotz Fellowship | University of Rochester Biochemisty Dept | | 1994 |
-
| 1996 | Medical Scientist Training Program Scholarship | NIH | | 1999 |
-
| 2000 | Stuber Fellowship | University of Rochester | | 1999 |
|
| Raphael Dolin Resident Research Award | University of Rochester | | 2000 |
-
| 2002 | NIH Training Grant T32-AI07169-16 | University of Rochester | | 2001 |
|
| Rheumatology Fellow Award | American College of Rheumatology | | 2003 |
|
| Buswell Fellowship | University of Rochester Dept of Medicine | | 2005 |
|
| Edmund Dubois Memorial Lectureship Award | American College of Rheumatology | | 2006 |
-
| 2008 | Lawrence Kohn Senior Teaching Fellow | | 2008 |
|
| Eisenberg Memorial Lupus Lectureship | University of MO-Columbia |
-
Marian V, Anolik JH. Treatment targets in systemic lupus erythematosus: biology and clinical perspective. Arthritis Res Ther. 2012; 14 Suppl 4:S3.
-
Ambatipudi KS, Swatkoski S, Moresco JJ, Tu PG, Coca A, Anolik JH, Gucek M, Sanz I, Yates JR, Melvin JE. Quantitative proteomics of parotid saliva in primary Sjögren's syndrome. Proteomics. 2012 Oct; 12(19-20):3113-20.
-
Ichikawa HT, Conley T, Muchamuel T, Jiang J, Lee S, Owen T, Barnard J, Nevarez S, Goldman BI, Kirk CJ, Looney RJ, Anolik JH. Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells. Arthritis Rheum. 2012 Feb; 64(2):493-503.
-
Kobie JJ, Zheng B, Bryk P, Barnes M, Ritchlin CT, Tabechian DA, Anandarajah AP, Looney RJ, Thiele RG, Anolik JH, Coca A, Wei C, Rosenberg AF, Feng C, Treanor JJ, Lee FE, Sanz I. Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor. Arthritis Res Ther. 2011; 13(6):R209.
-
Anolik J. Immunologic reconstitution after rituximab in systemic lupus erythematosus: why should we care? J Rheumatol. 2011 Apr; 38(4):587-9.
-
Marcus C, Dhillon G, Anolik JH. B cell immunology for the clinician. Pediatr Infect Dis J. 2011 Feb; 30(2):158-60.
-
Bekar KW, Owen T, Dunn R, Ichikawa T, Wang W, Wang R, Barnard J, Brady S, Nevarez S, Goldman BI, Kehry M, Anolik JH. Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus. Arthritis Rheum. 2010 Aug; 62(8):2443-57.
-
Marston B, Palanichamy A, Anolik JH. B cells in the pathogenesis and treatment of rheumatoid arthritis. Curr Opin Rheumatol. 2010 May; 22(3):307-15.
-
Ahmed S, Anolik JH. B-cell biology and related therapies in systemic lupus erythematosus. Rheum Dis Clin North Am. 2010 Feb; 36(1):109-30, viii-ix.
-
Looney RJ, Anolik J, Sanz I. A perspective on B-cell-targeting therapy for SLE. Mod Rheumatol. 2010 Feb; 20(1):1-10.
-
Palanichamy A, Barnard J, Zheng B, Owen T, Quach T, Wei C, Looney RJ, Sanz I, Anolik JH. Novel human transitional B cell populations revealed by B cell depletion therapy. J Immunol. 2009 May 15; 182(10):5982-93.
-
Coca A, Anolik JH. Two negative randomized controlled trials in lupus: now what? F1000 Med Rep. 2009; 1.
-
Anolik JH, Looney RJ, Lund FE, Randall TD, Sanz I. Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets. Immunol Res. 2009; 45(2-3):144-58.
-
Coca A, Anolik JH. Targeted biologic approaches to the treatment of systemic vasculitis. Clin Rev Allergy Immunol. 2008 Oct; 35(1-2):79-87.
-
Walker AR, Kleiner A, Rich L, Conners C, Fisher RI, Anolik J, Friedberg JW. Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma. Cancer Invest. 2008 May; 26(4):431-3.
-
Sanz I, Wei C, Lee FE, Anolik J. Phenotypic and functional heterogeneity of human memory B cells. Semin Immunol. 2008 Feb; 20(1):67-82.
-
Nicholas MW, Dooley MA, Hogan SL, Anolik J, Looney J, Sanz I, Clarke SH. A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE. Clin Immunol. 2008 Feb; 126(2):189-201.
-
Mehta LR, Samuelsson MK, Kleiner AK, Goodman AD, Anolik JH, Looney RJ, Schwid SR. Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome. Mult Scler. 2008 Apr; 14(3):425-7.
-
Anolik JH, Ravikumar R, Barnard J, Owen T, Almudevar A, Milner EC, Miller CH, Dutcher PO, Hadley JA, Sanz I. Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks. J Immunol. 2008 Jan 15; 180(2):688-92.
-
Ravikumar R, Anolik J, Looney RJ. Vaccine responses in patients with rheumatoid arthritis. Curr Rheumatol Rep. 2007 Oct; 9(5):407-15.
-
Anolik JH, Barnard J, Owen T, Zheng B, Kemshetti S, Looney RJ, Sanz I. Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy. Arthritis Rheum. 2007 Sep; 56(9):3044-56.
-
Wei C, Anolik J, Cappione A, Zheng B, Pugh-Bernard A, Brooks J, Lee EH, Milner EC, Sanz I. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol. 2007 May 15; 178(10):6624-33.
-
Sanz I, Anolik JH, Looney RJ. B cell depletion therapy in autoimmune diseases. Front Biosci. 2007; 12:2546-67.
-
Anolik JH. B cell biology and dysfunction in SLE. Bull NYU Hosp Jt Dis. 2007; 65(3):182-6.
-
Anolik JH, Friedberg JW, Zheng B, Barnard J, Owen T, Cushing E, Kelly J, Milner EC, Fisher RI, Sanz I. B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny. Clin Immunol. 2007 Feb; 122(2):139-45.
-
Looney RJ, Anolik J, Sanz I. New therapies for systemic lupus erythematosus: cellular targets. Rheum Dis Clin North Am. 2006 Feb; 32(1):201-15, xi.
-
Sabahi R, Anolik JH. B-cell-targeted therapy for systemic lupus erythematosus. Drugs. 2006; 66(15):1933-48.
-
Cappione A, Anolik JH, Pugh-Bernard A, Barnard J, Dutcher P, Silverman G, Sanz I. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Invest. 2005 Nov; 115(11):3205-16.
-
Anolik JH, Aringer M. New treatments for SLE: cell-depleting and anti-cytokine therapies. Best Pract Res Clin Rheumatol. 2005 Oct; 19(5):859-78.
-
Sanz I, Anolik J. Reconstitution of the adult B cell repertoire after treatment with rituximab. Arthritis Res Ther. 2005; 7(5):175-6.
-
Milner EC, Anolik J, Cappione A, Sanz I. Human innate B cells: a link between host defense and autoimmunity? Springer Semin Immunopathol. 2005 Mar; 26(4):433-52.
-
Looney RJ, Anolik J, Sanz I. Treatment of SLE with anti-CD20 monoclonal antibody. Curr Dir Autoimmun. 2005; 8:193-205.
-
Anolik JH, Barnard J, Cappione A, Pugh-Bernard AE, Felgar RE, Looney RJ, Sanz I. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum. 2004 Nov; 50(11):3580-90.
-
Anolik J, Sanz I. B cells in human and murine systemic lupus erythematosus. Curr Opin Rheumatol. 2004 Sep; 16(5):505-12.
-
Looney RJ, Anolik JH, Campbell D, Felgar RE, Young F, Arend LJ, Sloand JA, Rosenblatt J, Sanz I. B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab. Arthritis Rheum. 2004 Aug; 50(8):2580-9.
-
Looney RJ, Anolik J, Sanz I. B cells as therapeutic targets for rheumatic diseases. Curr Opin Rheumatol. 2004 May; 16(3):180-5.
-
Cappione AJ, Pugh-Bernard AE, Anolik JH, Sanz I. Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes. J Immunol. 2004 Apr 1; 172(7):4298-307.
-
Looney RJ, Anolik J, Sanz I. B lymphocytes in systemic lupus erythematosus: lessons from therapy targeting B cells. Lupus. 2004; 13(5):381-90.
-
Anolik J, Sanz I, Looney RJ. B cell depletion therapy in systemic lupus erythematosus. Curr Rheumatol Rep. 2003 Oct; 5(5):350-6.
-
Anolik J, Looney RJ, Bottaro A, Sanz I, Young F. Down-regulation of CD20 on B cells upon CD40 activation. Eur J Immunol. 2003 Sep; 33(9):2398-409.
-
Anolik JH, Campbell D, Felgar RE, Young F, Sanz I, Rosenblatt J, Looney RJ. The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus. Arthritis Rheum. 2003 Feb; 48(2):455-9.
-
Anolik JH, Blumberg N, Snider J, Francis CW. Posttransfusion purpura secondary to an alloantibody reactive with HPA-5a (Br(b)). Transfusion. 2001 May; 41(5):633-6.
-
Anolik JH, Wildy K, Cohn SE, Marquardt JD, Totterman S, Zwillich SH. Multifocal Staphylococcus aureus infection originating from the sacroiliac joint in a patient with rheumatoid arthritis. J Rheumatol. 2001 Jan; 28(1):217-20.
-
Anolik JH, Di Giovanna JJ, Gaspari AA. Effect of isotretinoin therapy on natural killer cell activity in patients with xeroderma pigmentosum. Br J Dermatol. 1998 Feb; 138(2):236-41.
-
Sathya G, Li W, Klinge CM, Anolik JH, Hilf R, Bambara RA. Effects of multiple estrogen responsive elements, their spacing, and location on estrogen response of reporter genes. Mol Endocrinol. 1997 Dec; 11(13):1994-2003.
-
Anolik JH, Klinge CM, Brolly CL, Bambara RA, Hilf R. Stability of the ligand-estrogen receptor interaction depends on estrogen response element flanking sequences and cellular factors. J Steroid Biochem Mol Biol. 1996 Dec; 59(5-6):413-29.
-
Anolik JH, Klinge CM, Hilf R, Bambara RA. Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence, and ligand. Biochemistry. 1995 Feb 28; 34(8):2511-20.
-
Anolik JH, Klinge CM, Bambara RA, Hilf R. Differential impact of flanking sequences on estradiol- vs 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA. J Steroid Biochem Mol Biol. 1993 Dec; 46(6):713-30.
|
Anolik's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
